Therapeutic immunization with autologous monocyte-derived dendritic cells (DCs) loaded
with heat-inactivated autologous human immunodeficiency virus type 1 (HIV-1) in 12 patients …

Despite the availability of effective combined antiretroviral treatment, many patients still
present with advanced HIV infection, often accompanied by an AIDS-defining disease. A …

Dendritic cells have a central role in HIV infection. On one hand, they are essential to induce
strong HIV-specific CD4 + helper T-cell responses that are crucial to achieve a sustained …

Background: This study addresses the dynamic of viral load rebound and immune system
changes in a cohort of eight consecutive HIV-1-infected patients in very early stages [all the …

Current treatment guidelines for HIV infection recommend a relatively late initiation of highly
active antiretroviral therapy (HAART). Nevertheless, there is still a concern that immune …

Combination antiretroviral therapy (cART) greatly improves survival and quality of life of HIV-1–infected
patients; however, cART must be continued indefinitely to prevent viral rebound …

Potent antiretroviral therapy (ART) suppresses HIV-1 viral replication and results in
decreased morbidity and mortality. However, prolonged treatment is associated with drug-induced …

Background According to the "autovaccination hypothesis," reexposure to human
immunodeficiency virus (HIV) during treatment interruptions may stimulate the HIV-specific immune …

A double-blinded, controlled study of vaccination of untreated patients with chronic human
immunodeficiency virus type 1 (HIV-1) infection with 3 doses of autologous monocyte-derived …

Plasma stromal cell–derived factor (SDF)-1 levels, SDF1-3′A polymorphism, and CXCR4
+ T lymphocytes in relation to resistance to human immunodeficiency virus (HIV)-1 infection …